By Professor Andrew Stewart Day

Preprints

Coffey MJ; van Dorst J; Pushpakumara BLDU; Halim J; Hudson J; Plush L; Christi K; Foster C; Carzino R; Zajakovski N; Appleton L; Cheney J; Wood J; Monaghan SJ; Rawlinson W; Day AS; Oliver M; Ranganathan S; Selvadurai H; Wainwright C; Thomas T; Jaffe A; Ooi CY, 2025, Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with Cystic Fibrosis (The “PEARL-CF” Study), http://dx.doi.org/10.64898/2025.12.04.25341620

Brown S; Wall CL; Frampton C; Gearry RB; Day AS, 2024, Exclusive Enteral Nutrition as Induction Therapy for Paediatric Crohn Disease – Efficacy, Outcomes and Predictors of Response over a Ten-Year Period, http://dx.doi.org/10.20944/preprints202409.1531.v1

E TK; Wakefield C; Signorelli C; Day A; Vernon-Roberts A; Ooi C, 2023, Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: A multi-stakeholder assessment of patients’ and professionals’ perspectives, http://dx.doi.org/10.22541/au.168271385.50624670/v1

Back to profile page